Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of a Novel Nasal Conformer in Pediatric Patients

NCT: NCT06885801 · ENROLLING_BY_INVITATION

NCT IDNCT06885801
StatusENROLLING_BY_INVITATION
Start Date2025-06-01
Completion2030-12-01
SponsorEast Tennessee Children's Hospital (OTHER)
First posted
Last updated

Brief Summary

This study compares the current commercially available nasal conformer available for use in cleft lip repair and nasal scar release to a novel, anatomically shaped conformer based upon typical nasal airspace shape. This will follow patients using both of these types of splints during the post-operative healing process with one group starting with the standard splint and then moving to the anatomic conformer and the second group beginning with the anatomic and them moving to the standard conformer. This study will evaluate the patient experience and outcomes of the 2 types of conformers, looking at the discomfort, device dislodgements, ease of use and occurrence of complications such as skin irritation and rashes or skin breakdown.

Frequently Asked Questions

What is Evaluation of a Novel Nasal Conformer in Pediatric Patients?

Evaluation of a Novel Nasal Conformer in Pediatric Patients is a clinical trial registered under NCT06885801. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06885801?

The current status of NCT06885801 (Evaluation of a Novel Nasal Conformer in Pediatric Patients) is: ENROLLING_BY_INVITATION.

When did Evaluation of a Novel Nasal Conformer in Pediatric Patients start?

Evaluation of a Novel Nasal Conformer in Pediatric Patients started on 2025-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.